Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement

Area of Science:

• Pharmacology
• Clinical Trials
• Integrative Medicine

Background:

• Herbal medicinal products exhibit significant variability in content and quality.
• Randomized controlled trials (RCTs) are crucial for evaluating herbal medicine efficacy.
• Existing reporting guidelines require specific adaptations for herbal interventions.

Framework:

• The study aimed to elaborate on the CONSORT checklist for herbal medicine RCTs.
• Recommendations focused on context-specific reporting of herbal interventions.
• Nine items of the CONSORT checklist were adapted, with a focus on intervention details.

Implementation:

• A consensus meeting with 16 participants in Toronto, Canada, was convened.
• Telephone discussions informed the development of the recommendations.
• The consensus process ensured expert input for guideline refinement.

Implications:

• Improved reporting standards will enhance the transparency and reproducibility of herbal medicine RCTs.
• These recommendations facilitate clearer communication of herbal intervention characteristics.
• Enhanced reporting supports more accurate interpretation of research findings in integrative medicine.